Prashant Jain’s investment tip: Don’t look at PE multiples this year, go by financials
“Investing is about right understanding and it needs a lot of patience,” Jain said.
HNIs dared to buy stocks worst hit by Covid-19, paid through the nose
Some 16 BSE500 stocks saw over 200 basis points jump in HNI stake in Ma...
Pharma emerges as most preferred sector among MFs
Earnings downgrade in the sector is likely to be the lowest among all sectors.
Bajaj Finance, Nestle, Sun Pharma among 9 stocks that analysts say can offer good returns over 3-4 weeks
With outlook for market uncertain, analysts are advising to adopt stock-specific approach.
Share market update: Pharma shares gain; Cadila Healthcare climbs 5%
The Nifty Pharma index was trading 1.01 per cent up at 9240.55.
Share market update: Pharma shares slip; Aurobindo Pharma dips 3%
The Nifty Pharma index was trading 1.03 per cent down at 9151.4 .
Share market update: Pharma shares rise; Dr Reddy's Labs gain 3%
The Nifty Pharma index was trading 1.84 per cent up at 9316.15 .
Share market update: Pharma shares down; Lupin slips 3%
The Nifty Pharma index was trading 0.73 per cent down at 9317.05 .
This smallcap firm to work on Covid-19 vaccine; shares rally 20%
Indian Institute of Technology Guwahati and Hester Biosciences expect the vaccine to be ready by the end of this year.
14 vaccine candidates from India look promising: Dr Renu Swarup, Department of Biotechnology
Human trials for at least 3-4 candidates are likely to begin in the next 2-6 months. Biotechnology Industry Research Investment Council (BIRAC) a public sector of Department of Biotechnology, has been at the forefront since the inception of the COVID crisis.
Share market update: Pharma shares down; Lupin slips 4%
The Nifty Pharma index was trading 2.46 per cent down at 9365.6 .
US pharma giant seeks marketing authorisation from India for remdesivir
"Gilead Sciences has applied seeking marketing authorisation for its anti-viral drug remdesivir to India's Central Drugs Standard Control Organisation (CDSCO). The CDSCO will examine the application with the help of the expert committee. It will take a final decision based on the recommendations of the expert committee," a source said.
Up 125% in a month and analysts say this stock has more steam left
The brisk rally in the stock has come against a 4 per cent rise in Sensex in last one month.
Covid count, inflation data, stimulus hopes among key factors that may drive market this week
Indian financial markets will be closed on Tuesday on account of Ambedkar Jayanti.
Share market update: Pharma shares rise; Aurobindo Pharma gains 2%
The Nifty Pharma index was trading 0.51 per cent up at 9429.4 .
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service